Total planned funding: $202,180,788
Allocations
Countries/Regions
Eswatini | $202,180,788 |
Organizational Types
University | $45,883,749 |
Private Contractor | $41,827,658 |
NGO | $41,023,900 |
Unknown | $35,154,078 |
Own Agency | $26,201,332 |
Host Country Government Agency | $8,103,560 |
Multi-lateral Agency | $2,033,840 |
Implementing Agency | $759,600 |
FBO | $742,500 |
Other USG Agency | $450,571 |
Program Areas
Care | $63,929,020 |
Prevention | $41,155,845 |
Treatment | $35,994,096 |
Governance and Systems | $30,965,959 |
Management and Operations | $17,993,271 |
Testing | $12,142,597 |
Budget Codes
HTXS: Treatment: Adult Treatment | $27,681,835 |
HBHC: Care: Adult Care and Support | $26,784,315 |
HVMS: Management and Operations | $17,993,271 |
HKID: Care: Orphans and Vulnerable Children | $17,317,050 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $13,831,706 |
HVTB: Care: TB/HIV | $13,425,153 |
OHSS: Health Systems Strengthening | $12,598,770 |
HVSI: Strategic Information | $12,579,918 |
HVCT: Testing: HIV Testing and Counseling | $12,142,597 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $9,953,306 |
HVOP: Sexual Prevention: Other Sexual Prevention | $8,665,395 |
PDCS: Care: Pediatric Care and Support | $6,402,502 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $6,368,438 |
HLAB: Laboratory Infrastructure | $5,787,271 |
PDTX: Treatment: Pediatric Treatment | $4,783,113 |
HTXD: Treatment: ARV Drugs | $3,529,148 |
HMBL: Biomedical Prevention: Blood Safety | $2,337,000 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$42,663,358
Countries/Regions
Not Available:
$35,154,078
Countries/Regions
Pact, Inc.:
$23,500,745
Countries/Regions
USG Aggregated Agencies:
$19,851,332
Countries/Regions